(Q33408184)

26 July 2017

title

Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes (English)

1 reference

26 July 2017

13

Hagop Kantarjian

1 reference

26 July 2017

4

Stefan Faderl

1 reference

26 July 2017

5

Zeev Estrov

1 reference

26 July 2017

2

Elias Jabbour

1 reference

26 July 2017

3

Gautam Borthakur

1 reference

26 July 2017

Guillermo Garcia-Manero

1

object named as

Guillermo Garcia-Manero

1 reference

26 July 2017

10

Jesus G Berdeja

1 reference

26 July 2017

7

Sirisha Maddipoti

1 reference

26 July 2017

8

Lucy A Godley

1 reference

26 July 2017

Hui Yang

6

1 reference

26 July 2017

Nashat Gabrail

9

1 reference

26 July 2017

Ahmed Nadeem

11

1 reference

26 July 2017

Laurent Kassalow

12

1 reference

26 July 2017

language of work or name

English

0 references

publication date

3 June 2013

1 reference

Journal of Clinical Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

31

1 reference

26 July 2017

issue

20

1 reference

26 July 2017

page(s)

2548-2553

1 reference

Integrating care for patients with lower risk myelodysplastic syndrome

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Outcome--adaptive randomization: is it useful?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Cause of death in patients with lower-risk myelodysplastic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

International scoring system for evaluating prognosis in myelodysplastic syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

A prognostic score for patients with lower risk myelodysplastic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4878053

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23733767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2012.44.6823

1 reference

26 July 2017

1 reference

26 July 2017

1 reference